ArticleResearch in social & administrative pharmacy : RSAP2025
Practical naloxone communication tips for pharmacists: Lessons learned from the Linguistic Model of Patient Participation in Care.
Article in Research in social & administrative pharmacy : RSAP, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundOpioid overdose is an ongoing public health issue in the rural United States and can be countered by increasing access to the opioid antagonist naloxone. Community pharmacists are well-positioned to offer and dispense naloxone to patients at risk of opioid overdose, but still experience a range of communication barriers. Understanding rural patient communication preferences is essential to prepare pharmacists to discuss naloxone in a patient-centered manner.
objectiveTo explore rural community pharmacists' and patients' naloxone communication preferences employing the Linguistic Model of Patient Participation in Care (LM).
methodsIn-depth qualitative interviews were conducted with 40 community pharmacists and 40 patients from rural areas in Alabama, Iowa, North Carolina, and Wisconsin. After a thematic analysis of the interview transcripts, three code reports were selected for a secondary qualitative analysis informed by the LM.
resultsAll elements described in the LM (Predisposing Factors, Enabling Factors, And Provider's Communication Style) were associated with patient-pharmacist naloxone communication. The analysis revealed four additional factors not accounted for in the model: Stigma, Privacy, Insurance Coverage and Price, and Collaboration with Physician.
conclusionPatient-pharmacist naloxone conversations are impacted by the factors described in the LM, as well as several pharmacy-specific factors which were included in an adapted conceptual model. Future studies should consider these findings when developing interventions to improve patient-pharmacist communication and pharmacists can utilize the practical tips provided to actively address the opioid epidemic.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.